Physician profile
Christopher S Hall
NPI 1174508295
$14,774.04
in general payments reported to CMS, 2019-2025
13 companies · $73.31 in 2025
The $73.31 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $146 · 2020: $12K · 2022: $2,278 · 2023: $37.46 · 2024: $41.36 · 2025: $73.31.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $152.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $152.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intravu INC. | $12,120.15 | 2020 | |
| Arthrex, INC. | $1,379.68 | 2022 | |
| Medinc of Texas | $827.05 | 2022 | |
| Abbott Laboratories | $130.56 | 2022-2025 | Proclaim |
| Spinesmith Holdings, LLC | $80.50 | 2019 | |
| Merz Pharmaceuticals, LLC | $78.82 | 2023-2024 | Xeomin |
| Stryker Corporation | $49.04 | 2019 | |
| Bioventus LLC | $21.20 | 2020 | |
| Smith+Nephew, INC. | $20.47 | 2020 | |
| Vericel Corporation | $18.08 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $17.75 | 2020 | |
| Depuy Synthes Sales INC. | $16.57 | 2019 | |
| Glaxosmithkline, LLC. | $14.17 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Hall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.